Comparison 	O
with 	O
alkaline 	B
phosphatases 	I
and 	O
5 	O
- 	O
nucleotidase 	O

Pharmacologic 	O
aspects 	O
of 	O
neonatal 	O
hyperbilirubinemia 	O
. 	O

When 	O
CSF 	B
[ 	O
HCO3 	O
-] 	O
is 	O
shown 	O
as 	O
a 	O
function 	O
of 	O
CSF 	B
PCO2 	O
the 	O
data 	O
of 	O
K 	O
- 	O
depleted 	O
rats 	O
are 	O
no 	O
longer 	O
displaced 	O
when 	O
compared 	O
to 	O
controls 	O
but 	O
still 	O
have 	O
a 	O
significantly 	O
greater 	O
slope 	O
( 	O
1 	O
. 	O
21 	O
+/- 	O
0 	O
. 	O
23 	O
vs 	O
. 	O

Flurazepam 	I
thus 	I
appears 	I
to 	I
be 	I
an 	I
effective 	I
hypnotic 	I
drug 	I
with 	I
the 	I
optimum 	I
dose 	I
for 	I
use 	I
in 	I
general 	I
practice 	I
being 	I
15 	I
mg 	I
at 	I
night 	I
. 	I

Beta 	B
blocking 	O
agents 	O
. 	O

When 	O
extracorporeal 	O
CO2 	O
removal 	O
approximated 	O
CO2 	O
production 	O
( 	B
VCO2 	I
), 	I
alveolar 	I
ventilation 	I
almost 	I
ceased 	I
. 	I

Intravenous 	O
administration 	O
( 	O
25 	O
mg 	O
/ 	O
kg 	O
) 	O
of 	O
carbonic 	B
anhydrase 	I
inhibitors 	I
( 	I
acetazolamide 	I
, 	I
methazolamide 	I
, 	I
dichlorphenamide 	I
, 	I
sulthiame 	I
) 	I
induced 	I
an 	I
early 	I
important 	I
rise 	I
of 	I
cortical 	I
p 	I
O2 	I
, 	I
which 	I
is 	I
not 	I
dependent 	I
on 	I
increase 	I
of 	I
p 	I
O2 	I
and 	I
p 	I
CO2 	I
and 	I
decrease 	I
of 	I
pH 	I
in 	I
arterial 	I
blood 	I
. 	I

Teratological 	I
study 	I
of 	I
etoperidone 	I
in 	I
the 	I
rat 	I
and 	I
rabbit 	I
. 	I

Colorectal 	I
polyps 	I
should 	I
be 	I
removed 	I
endoscopically 	I
whenever 	I
possible 	I
. 	I

The 	O
variable 	O
HMG 	B
dosage 	O
regimen 	O
was 	O
found 	O
to 	O
offer 	O
no 	O
advantages 	O
when 	O
compared 	O
with 	O
our 	O
standard 	O
daily 	O
dosage 	O
regimen 	O
. 	O

When 	O
the 	O
CO2 	O
content 	O
reached 	O
9 	B
Vol 	I
% 	I
the 	I
animals 	I
became 	I
apathic 	I
and 	I
lost 	I
body 	I
weight 	I
. 	I

Serum 	B
gamma 	I
glutamyltransferase 	I
in 	I
the 	I
diagnosis 	I
of 	I
liver 	I
disease 	I
in 	I
cattle 	I
. 	I

By 	O
contrast 	O
, 	O
secretory 	O
HI 	O
antibodies 	O
were 	O
not 	O
demonstrated 	O
at 	O
the 	O
onset 	O
of 	O
illness 	O
in 	O
any 	O
of 	O
the 	O
patients 	O
, 	O
but 	O
their 	O
formation 	O
started 	O
early 	O
and 	O
the 	O
antibodies 	O
reached 	O
maximal 	O
levels 	O
about 	O
10 	O
days 	O
after 	O
onset 	O
of 	O
illness 	O
. 	O

With 	O
the 	O
exception 	O
of 	O
virus 	B
assay 	I
and 	I
quantitation 	I
, 	I
these 	I
methods 	I
are 	I
simple 	I
and 	I
inexpensive 	I
enough 	I
to 	I
be 	I
done 	I
in 	I
typical 	I
shellfish 	I
microbiology 	I
laboratories 	I
. 	I

Characteristics 	O
of 	O
lipase 	B
activity 	O
. 	O

Takayasu 	I
' 	I
s 	I
disease 	I
: 	I
association 	I
with 	I
HLA 	I
- 	I
B5 	I
. 	I

SGPT 	B
, 	O
SGOT 	B
, 	O
and 	O
alkaline 	B
phosphatase 	I
concentrations 	O
were 	O
essentially 	O
normal 	O
in 	O
all 	O
subjects 	O
. 	O

